TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
OBIO

Orchestra BioMed Holdings Inc.

Healthcare · Biotechnology

6.00$ +0.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet OBIO
Line item 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
95.2% 83.7% 88.6% 93.6% 90.8% 94.0%
53.4% 73.5% 20.7% 32.1% 29.2% 30.2%
94.0% 80.6% 87.7% 92.0% 87.7% 92.7%
0.4% 0.9% 0.1% 0.1% 0.1% 0.1%
0.2% 0.5% 0.3% 0.2% 0.2% 0.3%
2.7% 8.3% – – – –
227.4% 626.6% 45.0% 28.5% 56.7% 44.8%
37.7% 90.5% 19.4% 11.8% 21.3% 14.6%
10.5% 14.8% 0.7% 0.7% 0.7% 0.7%
4.7% 15.0% 4.2% 3.0% 6.7% 5.3%
14.3% 27.2% 9.9% – 18.8% 12.4%
-127.4% -526.6% 55.0% 71.5% 43.3% 55.2%
-375.7% -1,228.1% -209.0% -261.4% -406.8% -315.7%
53.7% 151.2% 26.7% 34.9% 48.3% 41.6%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?